VCaP  Xenograft

 

 

Rincon Bio performs VCaP xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Prostate

Organism: Homo sapiens, human  /  Cell Type: epithelial  /  Tissue: prostate; derived from metastatic site: vertebral metastasis  /  Disease: cancer

 

Notes

VCaP cells were derived in 1997 from a 59 year old male caucasian with hormone refractory prostate cancer.  It is androgen sensitive in vitro and in vivo

in vivo

Used in xenografts to test the efficacy of novel cancer therapeutics.  Tumors develop after being injected into the flank of immunocompromised mice. 

Request Quote

Receive a quote within one business day for a VCaP Xenograft

Rincon Bio Growth Curve

VcAP Xenograft.png

Cell Line: VCAP

Mouse Strain: R2G2 (Envigo)

Gender: Male

Matrigel: 50:50

Cells Implanted per Animal: 3 x 10^6 

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are flexible and easy to work with.  And we take a personal interest in our clients' studies.